Please login to the form below

Not currently logged in
Email:
Password:

STDs

This page shows the latest STDs news and features for those working in and with pharma, biotech and healthcare.

Sexual health apps fail to attract smartphone users

Sexual health apps fail to attract smartphone users

HIV and STD apps not fulfilling their potential to assist with prevention and care. ... Among these, 71 per cent provided disease information about HIV/STDs, 36 per cent provided HIV/STD testing information or resources, 29 per cent included

Latest news

  • FDA cracks down on bogus STD drugs

    The US Food and Drug Administration is partnering with the US Federal Trade Commission on an effort to get unapproved products for sexually transmitted diseases (STDs) off the market. ... The two federal agencies are targeting products that make unproven

  • Talent fish or flounder

    It was a hypnotic that did it. I'd been "carrying the bag" up and down the Black Country for years, stuffed with NSAIDs, steroids and antibiotic drugs for STDs, bronchitis

  • Pfizer's 'Viva Viagra' TV ads come under fire

    The Aids Healthcare Foundation (AHF) has criticised US pharmaceutical company Pfizer for excluding a caution against sexually transmitted diseases (STDs) and HIV from its verbal medical risk warnings in the latest ... Pfizer has also buried important STD

  • 'Unscientific' HIV abstinence programmes continue in US

    There are no programmes which currently meet this standard. At most, abstinence programmes have been found to reduce teens' sexual activity for a year or two, without an effect on STD

  • Lost in translation?

    The nasty little English STD you picked up may be a MST in France or a German geschlechtskrankheit.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...